TRAXNasdaq

First Tracks Biotherapeutics, Inc.

Alert me on TRAX

Insider buys, 6 months

Congress trades, 6 months

Signals, 6 months

Six months

After each filing

Sep 5 Sale Ware J. Anthony Insider

1 week

−8.0%S&P −1.1%

1 month

−26.8%S&P +1.7%

3 months

Result in24 trading days

6 months

Result in87 trading days

Apr 23 Sale EcoR1 Capital, LLC Insider

1 week

+22.5%S&P +1.4%

1 month

−9.6%S&P +5.2%

3 months

+86.9%S&P +4.6%

6 months

+127.1%S&P +8.4%

Every purchase and sale on this ticker reported by a member of Congress or an insider, measured from the close of the first trading day after it became public to the close 1 week, 1 month, 3 months and 6 months later, each beside the S&P over the same days.

Filings for TRAX

49 held · newest 549 held · newest 2

Loading the filings.

See all 49 filings for TRAX

Aeon news and offers by email

New sources, new features and offers like our founding price. A few times a month at most. Stop any time.

Signal history

No signal for this ticker yet. A signal is written when insider buying here scores one dot or more.

Stakes

Sep 30, 2026 Schedule 13G, amended

BlackRock, Inc.: 7.2%, 2,558,473 shares

Jun 30, 2026 Schedule 13G

Chen Yu: 8.3%, 2,895,304 shares

Jun 30, 2026 Schedule 13G

Sirenia Capital Management LP: 7.2%, 2,495,777 shares

Jun 30, 2026 Schedule 13G

Affinity Asset Advisors, LLC: 5.8%, 2,032,012 shares

Jun 30, 2026 Schedule 13G

FMR LLC: 5.9%, 2,054,127 shares

Jun 30, 2026 Schedule 13G

BlackRock, Inc.: 5.5%, 1,919,376 shares

Apr 20, 2026 Schedule 13G

EcoR1 Capital, LLC: 9.1%, 3,174,519 shares

Schedule 13D is filed within 5 business days of crossing 5 percent by an investor who may seek to influence the company. Schedule 13G is filed by a passive holder, and a large institution has up to 45 days after the quarter end.

Government contracts, last 12 months

Awards of $10M and up, from USAspending · context, not a signal

No contracts of $10M or more in the last 12 months.

Lobbying

Last four quarters

No lobbying reports on file.